Reposted from WuXi STA
(2023年)Our Shanghai Waigqaoqiao site successfully passed its first drug product pre-approval inspection (PAI) by the US FDA. It is another milestone that the site starts to provide commercial drug product manufacturing services to the US market. Within the same week, the site also successfully passed two additional drug product PAIs by the China NMPA for two innovative drugs from its partners. Three successful drug product PAIs during one single week is a testimony to WuXi STA’s robust and reliable quality system.
Learn more about our industry-leading formulation development and manufacturing capability herehttps://www.stapharma.com/
- «前のできごと |
- 次のできごと»
- このできごとのURL:
コメント